However, a recent study showed that 17β-E2 inhibited the proliferation of human EC109 ESCC cells in a dose-dependent manner, which was inhibited by the ER antagonist ICI 182,780. This evidence concerns the gene ESR1 and esophageal squamous cell carcinoma.